Mount Vernon Cancer Centre pioneers first internal invivo dosimetry with TRUEnvivo® DOSEmapper™, revolutionising radiotherapy precision, patient safety, and treatment accuracy.

TrueInvivo’s® DOSEmapper™ showcased at BRSS, ensuring precise gamma knife dosimetry and improved radiation safety.

TRUEinvivo® receives CE Mark for DOSEmapper Reader, automating radiotherapy dose measurement for enhanced accuracy.

Dr. Shakardokht Jafari named 2024 Innovator of the Year at Dynamic Awards in Brighton's Grand Hotel.

TRUEinvivo® is pleased to announce that the patent for the DOSEmapper™ TLD bead strings and Automated DOSEmapper™ TLD Reader was granted in the EU on 6th January 2021

This order is for a number of DOSEmapper™ devices and for our DOSEmapper™ Bead Reading Service.